AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like San Diego's Halozyme Lands Potential $680M R&D Deal With Alexion December 6, 2017 Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania March 19, 2017 5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months March 21, 2017
Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania March 19, 2017